Docosahexaenoic acid-acylated phloridzin, a novel polyphenol fatty acid ester derivative, is cytotoxic to breast cancer cells

Carcinogenesis

Volumn 37, Issue 10, 2016, Pages 1004-1013

  Fernando, Wasundara ^a   Coombs, Melanie R Power ^a   Hoskin, David W ^a   Rupasinghe, H P Vasantha ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CYCLIN B1; CYCLIN DEPENDENT KINASE 1; CYTOTOXIC AGENT; DNA; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID ACYLATED PHLORIDZIN; FATTY ACID ESTER; KI 67 ANTIGEN; PHENAZINE METHOSULFATE; PHLORIZIN; POLYPHENOL DERIVATIVE; UNCLASSIFIED DRUG; CDK1 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; POLYPHENOL;

4T1 CELL LINE; ACYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOMA; BREAST EPITHELIUM CELL; CARCINOMA CELL; CELL KILLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; FIBROBLAST; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUMINESCENCE; MCF 7 CELL LINE; MDA MB 231 CELL LINE; MDA MB 468 CELL LINE; MOUSE; MOUSE MODEL; MTS ASSAY; NOD SCID MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; T 47D CELL LINE; TUMOR XENOGRAFT; TUNEL ASSAY; ANIMAL; BIOSYNTHESIS; BREAST NEOPLASMS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; GENETICS; MCF-7 CELL LINE; PATHOLOGY;

ACYLATION; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; CYCLIN B1; CYCLIN-DEPENDENT KINASES; DOCOSAHEXAENOIC ACIDS; FEMALE; HUMANS; MCF-7 CELLS; MICE; PHLORHIZIN; POLYPHENOLS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84991204133     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgw087     Document Type: Article

References (50)

1. Katzung, B.G. (2006) Basic and Clinical Pharmacology. 10th edn. McGraw Hill, UK.
2. Ovcaricek, T. et al. (2011) Triple negative breast cancer-prognostic factors and survival. Radiol. Oncol., 45, 46-52.
3. Al-Ejeh, F. et al. (2014) Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer. Oncogenesis, 3, e124.
4. Ziaullah et al. (2013) Biocatalytic synthesis, structural elucidation, antioxidant capacity and tyrosinase inhibition activity of long chain fatty acid acylated derivatives of phloridzin and isoquercitrin. Bioorg. Med. Chem., 21, 684-692.
5. Ren, W. et al. (2003) Flavonoids: promising anticancer agents. Med. Res. Rev., 23, 519-534.
6. Yao, H. et al. (2011) Dietary flavonoids as cancer prevention agents. J. Environ. Sci. Health. C Environ. Carcinog. Ecotoxicol. Rev., 29, 1-31.
7. Fernando, W. and Rupasinghe, H.P.V. (2013) Anticancer properties of phytochemicals present in medicinal plants of North America. In Kulka, M. (eds) Using Old Solutions to New Problems-Natural Drug Discovery in the 21st Century. InTech, Croatia. pp. 159-180.
8. Fernando, W. et al. (2015) Regulation of hypoxia-inducible factor-1a and vascular endothelial growth factor signaling by plant flavonoids. Mini Rev. Med. Chem., 15, 479-489.
9. Rupasinghe, H.P.V. et al. (2012) Polyphenols: Chemistry, Dietary Sources and Health Benefits. In Sun, J., Prasad, K.N., Ismail, A.B., Yang, X.Y. (eds) Polyphenols: Chemistry, Dietary Sources and Health Benefits. Nova Science Publishers, Inc. Hauppauge, NY, pp. 333-368.
10. Mellou, F. et al. (2006) Enzymatic esterification of flavonoids with unsaturated fatty acids: Effect of the novel esters on vascular endothelial growth factor release from K562 cells. Process Biochem., 41, 2029-2034.
11. Stevenson, D.E. et al. (2006) Direct acylation of flavonoid glycosides with phenolic acids catalysed by Candida antarctica lipase B (Novozym 435®). Enzyme Microb. Technol., 39, 1236-1241.
12. Ziaullah et al. (2016) Sonochemical enzyme-catalyzed regioselective acylation of flavonoid glycosides. Bioorg. Chem., 65, 17-25.
13. Mellou, F. et al. (2005) Biocatalytic preparation of acylated derivatives of flavonoid glycosides enhances their antioxidant and antimicrobial activity. J. Biotechnol., 116, 295-304.
14. Salem, J.H. et al. (2010) Effect of acyl donor chain length on isoquercitrin acylation and biological activities of corresponding esters. Process Biochem., 45, 382-389.
15. Nair, S.V. et al. (2014) Fatty acid esters of phloridzin induce apoptosis of human liver cancer cells through altered gene expression. PLoS One, 9, e107149.
16. Ardhaoui, M. et al. (2004) Acylation of natural flavonoids using lipase of candida antarctica as biocatalyst. J. Mol. Catal. B Enzym., 29, 63-67.
17. Nelson, J.A. et al. (1993) The efficacy of phloridzin and phloretin on tumor cell growth. Anticancer Res., 13, 2287-2292.
18. Schley, P.D. et al. (2005) Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat., 92, 187-195.
19. Lee, C.Y. et al. (2010) The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carcinoma proliferation. Int. J. Oncol., 36, 991-998.
20. Khan, N.A. et al. (2006) Docosahexaenoic acid inhibits cancer cell growth via p27Kip1, CDK2, ERK1/ERK2, and retinoblastoma phosphorylation. J. Lipid Res., 47, 2306-2313.
21. Connolly, J.M. et al. (1999) Effects of reduced dietary linoleic acid intake, alone or combined with an algal source of docosahexaenoic acid, on MDA-MB-231 breast cancer cell growth and apoptosis in nude mice. Nutr. Cancer, 35, 44-49.
22. Rose, D.P. et al. (1995) Influence of diets containing eicosapentaenoic or docosahexaenoic acid on growth and metastasis of breast cancer cells in nude mice. J. Natl. Cancer Inst., 87, 587-592.
23. Xue, M. et al. (2014) Docosahexaenoic acid inhibited the Wnt/ß-catenin pathway and suppressed breast cancer cells in vitro and in vivo. J. Nutr. Biochem., 25, 104-110.
24. Kang, K.S. et al. (2010) Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One, 5, e10296.
25. Sekhon-Loodu, S. et al. (2015) Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharide-induced inflammation in THP-1 differentiated macrophages. Int. Immunopharmacol., 25, 199-206.
26. Hoskins, C. et al. (2012) Dilemmas in the reliable estimation of the invitro cell viability in magnetic nanoparticle engineering: which tests and what protocols? Nanoscale Res. Lett., 7, 77.
27. Greenshields, A.L. et al. (2015) Piperine inhibits the growth and motility of triple-negative breast cancer cells. Cancer Lett., 357, 129-140.
28. Hilchie, A.L. et al. (2011) Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res., 13, R102.
29. Odiatou, E.M. et al. (2013) Identification of the factors responsible for the in vitro pro-oxidant and cytotoxic activities of the olive polyphenols oleuropein and hydroxytyrosol. Cancer Lett., 330, 113-121.
30. Wang, J. et al. (2010) Estrogenic and antiestrogenic activities of phloridzin. Biol. Pharm. Bull., 33, 592-597.
31. Duarte-Almeida, J.M. et al. (2007) Antiproliferative and antioxidant activities of a tricin acylated glycoside from sugarcane (Saccharum officinarum) juice. Phytochemistry, 68, 1165-1171.
32. Choi, S.U. et al. (1999) Effects of flavonoids on the growth and cell cycle of cancer cells. Anticancer Res., 19, 5229-5233.
33. Vidya Priyadarsini, R. et al. (2010) The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur. J. Pharmacol., 649, 84-91.
34. Zhao, R. et al. (2009) Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr. Cancer, 61, 397-407.
35. Vollmer, C.M. et al. (1999) p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res., 59, 4369-4374.
36. Hui, L. et al. (2006) Mutant p53 in MDA-MB-231 breast cancer cells is stabilized by elevated phospholipase D activity and contributes to survival signals generated by phospholipase D. Oncogene, 25, 7305-7310.
37. Abu, N. et al. (2014) Flavokawain A induces apoptosis in MCF-7 and MDAMB231 and inhibits the metastatic process in vitro. PLoS One, 9, e105244.
38. Chan, M.M. et al. (2006) Epigallocatechin-3-gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J. Cell. Physiol., 207, 389-396.
39. Fabiani, R. et al. (2009) Production of hydrogen peroxide is responsible for the induction of apoptosis by hydroxytyrosol on HL60 cells. Mol. Nutr. Food Res., 53, 887-896.
40. Kerksick, C. et al. (2005) The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J. Int. Soc. Sports Nutr., 2, 38-44.
41. Monasterio, A. et al. (2004) Flavonoids induce apoptosis in human leukemia U937 cells through caspase-and caspase-calpain-dependent pathways. Nutr. Cancer, 50, 90-100.
42. Granado-Serrano, A.B. et al. (2006) Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J. Nutr., 136, 2715-2721.
43. Shankar, S. et al. (2013) EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin. Mol. Cell. Biochem., 372, 83-94.
44. Zhang, W. et al. (2013) Galangin inhibits tumor growth and metastasis of B16F10 melanoma. J. Cell. Biochem., 114, 152-161.
45. Fang, J. et al. (2007) Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis, 28, 713-723.
46. Pratheeshkumar, P. et al. (2012) Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR-2 regulated AKT/mTOR/P70S6K signaling pathways. PLoS One, 7, e47516.
47. Chian, S. et al. (2014) Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo. Biochem. Biophys. Res. Commun., 447, 602-608.
48. Pratheeshkumar, P. et al. (2012) Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. PLoS One, 7, e52279.
49. Day, A.J. et al. (2000) Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett., 468, 166-170.
50. Malathi, P. et al. (1969) Phlorizin hydrolase: a ß-glucosidase of hamster intestinal brush border membrane. Biochim. Biophys. Acta Biomembr., 173, 245-256.